Literature DB >> 19066198

Evaluation of multiplex real-time PCR for detection of Haemophilus ducreyi, Treponema pallidum, herpes simplex virus type 1 and 2 in the diagnosis of genital ulcer disease in the Rakai District, Uganda.

T R Suntoke1, A Hardick, A A R Tobian, B Mpoza, O Laeyendecker, D Serwadda, P Opendi, C A Gaydos, R H Gray, M J Wawer, T C Quinn, S J Reynolds.   

Abstract

OBJECTIVE: To develop a real-time PCR assay that reliably and accurately detects the predominant sexually transmitted aetiological agents of genital ulcer disease (GUD) (Haemophilus ducreyi, Treponema pallidum and herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2)) and to assess the use of real-time PCR diagnostic testing in a rural African field site.
METHODS: Two multiplex real-time PCR reactions were used to detect H ducreyi/and HSV-1/HSV-2 in ulcer swabs from 100 people with symptomatic genital ulcers in rural Rakai, Uganda. Results were compared with syphilis, HSV-1 and HSV-2 serology.
RESULTS: Of 100 GUD samples analysed from 43 HIV positive and 57 HIV negative individuals, 71% were positive for one or more sexually transmitted infection (STI) pathogens by real-time PCR (61% for HSV-2, 5% for T pallidum, 3% for HSV-1, 1% for H ducreyi and 1% for dual H ducreyi/HSV-2). The frequency of HSV in genital ulcers was 56% (32/57) in HIV negative individuals and 77% (33/43) in HIV positive individuals (p = 0.037). Assay reproducibility was evaluated by repeat PCR testing in the USA with 96% agreement (kappa = 0.85).
CONCLUSIONS: STI pathogens were detected in the majority of GUD swab samples from symptomatic patients in Rakai, Uganda, by real-time PCR. HSV-2 was the predominant cause of genital ulcers. Real-time PCR technology can provide sensitive, rapid and reproducible evaluation of GUD aetiology in a resource-limited setting.

Entities:  

Mesh:

Year:  2008        PMID: 19066198      PMCID: PMC2692240          DOI: 10.1136/sti.2008.034207

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  28 in total

1.  Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda.

Authors:  Jordyn L Gamiel; Aaron A R Tobian; Oliver B Laeyendecker; Steven J Reynolds; Rhoda Ashley Morrow; David Serwadda; Ronald H Gray; Thomas C Quinn
Journal:  Clin Vaccine Immunol       Date:  2008-03-05

2.  Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. Rakai Project Team.

Authors:  R H Gray; M J Wawer; N K Sewankambo; D Serwadda; C Li; L H Moulton; T Lutalo; F Wabwire-Mangen; M P Meehan; S Ahmed; L A Paxton; N Kiwanuka; F Nalugoda; E L Korenromp; T C Quinn
Journal:  AIDS       Date:  1999-10-22       Impact factor: 4.177

3.  Increasing relative prevalence of HSV-2 infection among men with genital ulcers from a mining community in South Africa.

Authors:  W Lai; C Y Chen; S A Morse; Ye Htun; H G Fehler; H Liu; R C Ballard
Journal:  Sex Transm Infect       Date:  2003-06       Impact factor: 3.519

Review 4.  Epidemiology of herpes simplex virus type 2 infection in the developing world.

Authors:  Helen Weiss
Journal:  Herpes       Date:  2004-04

5.  Extended duration of herpes simplex virus DNA in genital lesions detected by the polymerase chain reaction.

Authors:  R W Cone; A C Hobson; J Palmer; M Remington; L Corey
Journal:  J Infect Dis       Date:  1991-10       Impact factor: 5.226

6.  Performance of the focus and Kalon enzyme-linked immunosorbent assays for antibodies to herpes simplex virus type 2 glycoprotein G in culture-documented cases of genital herpes.

Authors:  Rhoda Ashley Morrow; David Friedrich; Elizabeth Krantz
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

7.  Etiology of genital ulcer disease and association with human immunodeficiency virus infection in two tanzanian cities.

Authors:  Hinda J Ahmed; Judica Mbwana; Eva Gunnarsson; Karin Ahlman; Chalamilla Guerino; Liselott A Svensson; Fred Mhalu; Teresa Lagergard
Journal:  Sex Transm Dis       Date:  2003-02       Impact factor: 2.830

8.  Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera.

Authors:  R L Ashley; J Militoni; F Lee; A Nahmias; L Corey
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

9.  Rapid and specific detection of Mycobacterium tuberculosis by using the Smart Cycler instrument and a specific fluorogenic probe.

Authors:  Timothy J Cleary; Gladys Roudel; Ofelia Casillas; Nancimae Miller
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

Review 10.  Chancroid and Haemophilus ducreyi.

Authors:  S A Morse
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

View more
  18 in total

1.  Herpes diagnostic tests and their use.

Authors:  Nicholas J Van Wagoner; Edward W Hook
Journal:  Curr Infect Dis Rep       Date:  2012-04       Impact factor: 3.725

Review 2.  Comparison of Diagnostic Accuracy of PCR Targeting the 47-Kilodalton Protein Membrane Gene of Treponema pallidum and PCR Targeting the DNA Polymerase I Gene: Systematic Review and Meta-analysis.

Authors:  Angèle Gayet-Ageron; Christophe Combescure; Stephan Lautenschlager; Béatrice Ninet; Thomas V Perneger
Journal:  J Clin Microbiol       Date:  2015-08-26       Impact factor: 5.948

3.  Passive immunization with a polyclonal antiserum to the hemoglobin receptor of Haemophilus ducreyi confers protection against a homologous challenge in the experimental swine model of chancroid.

Authors:  Isabelle Leduc; William G Fusco; Neelima Choudhary; Patty A Routh; Deborah M Cholon; Marcia M Hobbs; Glen W Almond; Paul E Orndorff; Christopher Elkins
Journal:  Infect Immun       Date:  2011-06-06       Impact factor: 3.441

4.  Genital ulceration does not increase HIV-1 shedding in cervical or vaginal secretions of women taking antiretroviral therapy.

Authors:  Susan M Graham; Linnet Masese; Ruth Gitau; Barbra A Richardson; Kishor Mandaliya; Norbert Peshu; Walter Jaoko; Jeckoniah Ndinya-Achola; Julie Overbaugh; R Scott McClelland
Journal:  Sex Transm Infect       Date:  2010-10-27       Impact factor: 3.519

5.  Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.

Authors:  Mary K Grabowski; Ronald H Gray; Fred Makumbi; Joseph Kagaayi; Andrew D Redd; Godfrey Kigozi; Steven J Reynolds; Fred Nalugoda; Tom Lutalo; Maria J Wawer; David Serwadda; Thomas C Quinn; Aaron A R Tobian
Journal:  Lancet Glob Health       Date:  2015-06-17       Impact factor: 26.763

6.  Clinical value of Treponema pallidum real-time PCR for diagnosis of syphilis.

Authors:  R Heymans; J J van der Helm; H J C de Vries; H S A Fennema; R A Coutinho; S M Bruisten
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

7.  Herpes simplex virus type-2 assay specificity and male circumcision to reduce herpes simplex virus type-2 acquisition.

Authors:  Aaron A R Tobian; Godfrey Kigozi; Maria J Wawer; David Serwadda; Thomas C Quinn; Ronald H Gray
Journal:  AIDS       Date:  2013-01-02       Impact factor: 4.177

8.  Aetiology of genital ulcer disease in female partners of male participants in a circumcision trial in Uganda.

Authors:  A E Brankin; A A R Tobian; O Laeyendecker; T R Suntoke; A Kizza; B Mpoza; G Kigozi; F Nalugoda; B Iga; M Z Chen; R H Gray; M J Wawer; T C Quinn; S J Reynolds
Journal:  Int J STD AIDS       Date:  2009-09       Impact factor: 1.359

9.  Financial implications of male circumcision scale-up for the prevention of HIV and other sexually transmitted infections in a sub-Saharan African community.

Authors:  Seema Kacker; Kevin D Frick; Thomas C Quinn; Ronald H Gray; Aaron A R Tobian
Journal:  Sex Transm Dis       Date:  2013-07       Impact factor: 2.830

10.  Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy.

Authors:  Aaron A R Tobian; Mary K Grabowski; David Serwadda; Kevin Newell; Paschal Ssebbowa; Veronica Franco; Fred Nalugoda; Maria J Wawer; Ronald H Gray; Thomas C Quinn; Steven J Reynolds
Journal:  J Infect Dis       Date:  2013-06-28       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.